Keep An Eye On FLGT, CCXI, ADBE…

(RTTNews) - What's moving these stocks?

1. EverQuote Inc. (EVER)

EverQuote is an online insurance marketplace.

The stock closed Monday's trading at $21.77, and was up 25.4% in after-hours.

News: The company announced financial results for the third quarter ended September 30, 2019, and provided fourth-quarter and full-year revenue outlook.

The company reported net income in the third quarter of $173000 or $0.01 per share compared to net loss of $3.81 million or $0.15 per share in the same quarter a year ago. Analysts expected the company to report net loss of $0.08 per share.

Third-quarter revenue was $67.1 million, an increase of 61% from $41.75 million in the year-earlier quarter. The analysts' revenue estimate was $58.3 million.

Looking forward to fourth quarter, the company expects revenue to be in the range of $67.0 million to $69.0 million. Analysts expect revenue of only $51.65 million for the period.

For the full-year, the company raised its revenue guidance to the range of $215.0 million - $219.0 million from its earlier forecast of $215.0 million - $219.0 million. Analysts have a consensus revenue estimate of $217.86 million.

2. Fulgent Genetics, Inc. (FLGT)

Fulgent Genetics is a technology company that offers genetic testing services.

The stock closed Monday's trading at $9.40, and was up 19.04% in after-hours.

News: The company announced financial results for the third quarter ended September 30, 2019.

Net income for the third quarter was $1.5 million, or $0.08 per share compared with net loss of $595,000 or $0.03 per share in the same quarter last year. On a non-GAAP basis, income was $2.6 million, or $0.14 per share for the third quarter of 2019.

Third-quarter revenue was $10.3 million, an increase of 84% from $5.6 million in the year-ago quarter.

Analysts expected the company to report earnings of $0.03 per share on revenues of $8.45 million for the third quarter.

3. ChemoCentryx Inc. (CCXI)

ChemoCentryx is a clinical-stage biopharmaceutical company.

The stock closed Monday's trading at $9.36, and was up 11.86% in after-hours.

News: The company announced financial results for the third quarter ended September 30, 2019.

Net loss for the third quarter was $12.86 million or $0.22 per share compared with $10.89 million or $0.22 per share in the year-ago period. Analysts' expected the company to report loss of $0.28 per share.

Revenue was $10.58 million for the third quarter, compared to $8.98 million for the same period a year ago.

Near term Catalyst:

Top-line data from ADVOCATE, a phase III study of the company's lead drug candidate, Avacopan, in patients with ANCA Vasculitis is expected in the fourth quarter. ANCA vasculitis is an autoimmune disease affecting small blood vessels in the body.

4. Shenandoah Telecommunications Company (SHEN)

Shenandoah Telecommunications is a telecommunications service provider.

The stock closed Monday's trading at $32.93, and was up 11.42% in after-hours.

Recent event: On October 31, the company reported financial results for the third quarter of 2019. It also announced a share buyback and an increase in annual dividend.

Net income in the third quarter was $14.4 million or $0.29 per share compared with $15.5 million or $0.31 per share in the year-earlier quarter. Analysts' earnings estimate was $0.32 per share. Revenue in the third quarter was $155.2 million compared with $158.7 million in the same quarter last year.

On October 30, the company announced a share repurchase of up to $80 million of its outstanding common stock, effective November 4, 2019.

Also, the company announced an annual dividend of $0.29 per share, an increase of 7.4% from last year. The company has paid an annual dividend for 59 consecutive years and has increased its dividend in each of the past seven years.

5. Adobe Inc. (ADBE)

Adobe is a diversified software company.

The stock closed Monday's trading at $277.50, and was up 4.25% in after-hours.

News: The company provided preliminary FY2020 guidance and reaffirmed its fourth-quarter outlook.

Looking forward to FY2020, the company sees revenue of approximately $13.15 billion, compared with analysts' estimates of $13.14 billion. Adjusted earnings are expected to be nearly $9.75 per share. The consensus estimate for earnings is projected at $9.7 per share.

The company currently expects its fourth-quarter adjusted earnings to be approximately $2.25 per share, while analysts have a consensus estimate of $2.26 per share. Revenue for the fourth quarter is expected to be $2.97 billion, in line with analysts' expectations. Fourth-quarter results are expected to be reported on December 12, 2019.